These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18164223)

  • 41. Hereditary hemochromatosis: missed diagnosis or misdiagnosis?
    Cherfane CE; Hollenbeck RD; Go J; Brown KE
    Am J Med; 2013 Nov; 126(11):1010-5. PubMed ID: 24054178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
    Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.
    Phatak PD; Ryan DH; Cappuccio J; Oakes D; Braggins C; Provenzano K; Eberly S; Sham RL
    Blood Cells Mol Dis; 2002; 29(1):41-7. PubMed ID: 12482402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
    Aranda N; Viteri FE; Montserrat C; Arija V
    Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential HFE allele expression in hemochromatosis heterozygotes.
    Rosmorduc O; Poupon R; Nion I; Wendum D; Feder J; Béréziat G; Hermelin B
    Gastroenterology; 2000 Oct; 119(4):1075-86. PubMed ID: 11040194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary hemochromatosis: the clinical significance of the S65C mutation.
    Asberg A; Thorstensen K; Hveem K; Bjerve KS
    Genet Test; 2002; 6(1):59-62. PubMed ID: 12180078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
    Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B; Pita L; Gomes S; Gonçalves J; Faustino P
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.
    Zaloumis SG; Allen KJ; Bertalli NA; Turkovic L; Delatycki MB; Nicoll AJ; McLaren CE; English DR; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    J Gastroenterol Hepatol; 2015 Apr; 30(4):719-25. PubMed ID: 25311314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
    Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 54.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G
    Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.
    de Diego C; Murga MJ; Martínez-Castro P
    Genet Test; 2004; 8(3):263-7. PubMed ID: 15727249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SELDI-TOF MS detection of urinary hepcidin.
    Altamura S; Kiss J; Blattmann C; Gilles W; Muckenthaler MU
    Biochimie; 2009 Oct; 91(10):1335-8. PubMed ID: 19393287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.